Lack of funding halts MRSA study

02/24/2010 | Press and Journal (Aberdeen, Scotland), The

An international study focusing on the development of new treatments for methicillin-resistant Staphylococcus aureus has been stopped as a result of insufficient funds. The study was exploring the potential of a protein called calprotectin, which can inhibit MRSA's food source, as a treatment for the bacteria. The researchers hope their work will be revived in the future.

View Full Article in:

Press and Journal (Aberdeen, Scotland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Executive Medical Director
Aspirus Network Inc
Wausau, WI